|
| 38017663 | PERPRISE: A prospective non-interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic-clonic seizures: First interim analysis. | Epilepsia Open | 2024 |
| 36693811 | Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study. | Epilepsia Open | 2023 |
| 37756017 | Diagnostic Value of Intermittent Photic Stimulation Among Adult Patients in a Tertiary Referral Epilepsy Center: A Retrospective Study. | J Clin Neurophysiol | 2023 |
| 37684497 | Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records. | CNS Drugs | 2023 |
| 36855241 | Failure to use new breakthrough treatments for epilepsy. | Epilepsia | 2023 |
| 34427754 | PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice. | J Neurol | 2022 |
| 35705501 | Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures. | Neurology | 2022 |
| 35711112 | Onset of efficacy and adverse events during Cenobamate titration period. | Acta Neurol Scand | 2022 |
| 35912534 | Possible Association with Barbiturates. | Dtsch Arztebl Int | 2022 |
| 36088682 | Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies. | EBioMedicine | 2022 |
| 35168142 | Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications. | Seizure | 2022 |
| 34813673 | Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program. | Epilepsia | 2022 |
| 32990790 | [Cenobamate-a new perspective for epilepsy treatment]. | Nervenarzt | 2021 |
| 33602660 | Clinical experience of abrupt discontinuation of perampanel: a case series. | Epileptic Disord | 2021 |
| 33539600 | Status of clinical research in neurology in Germany-A national survey. | Eur J Neurol | 2021 |
| 33591415 | [SUDEP in brief - knowledge and practice recommendations on sudden unexpected death in epilepsy]. | Nervenarzt | 2021 |
| 33534134 | Everolimus in adult tuberous sclerosis complex patients with epilepsy: Too late for success? A retrospective study. | Epilepsia | 2021 |
| 33839453 | Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review. | Epilepsy Behav | 2021 |
| 33778964 | Epilepsy surgery: Late seizure recurrence after initial complete seizure freedom. | Epilepsia | 2021 |
| 34509033 | Practical guidance for the management of adults receiving adjunctive cenobamate for the treatment of focal epilepsy-expert opinion. | Epilepsy Behav | 2021 |
| 34030934 | The times they are a-changin - Don´t panic with a generic! | Seizure | 2021 |
| 33470139 | Cenobamate tablets as a treatment for focal-onset seizures in adults. | Expert Rev Clin Pharmacol | 2021 |
| 32199090 | Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures - Authors' reply. | Lancet Neurol | 2020 |
| 31743818 | Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? - A case series. | Epilepsy Res | 2020 |
| 31944276 | Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies. | Epilepsia | 2020 |
| 31734103 | Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. | Lancet Neurol | 2020 |
| 33197757 | Is the anticonvulsant activity of levetiracetam dose-dependent? | Seizure | 2020 |
| 33241213 | Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach. | Brain Commun | 2020 |
| 32920375 | Visual illustration supporting patient-physician communication in epilepsy: A validation and reliability study of seizure images. | Epilepsy Behav | 2020 |
| 32623096 | Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe. | Epilepsy Res | 2020 |
| 32673968 | Alterations of intracerebral connectivity in epilepsy patients with secondary bilateral synchrony. | Epilepsy Res | 2020 |
| 32155575 | Could the 2017 ILAE and the four-dimensional epilepsy classifications be merged to a new "Integrated Epilepsy Classification"? | Seizure | 2020 |
| 32445879 | Desynchronization of temporal lobe theta-band activity during effective anterior thalamus deep brain stimulation in epilepsy. | Neuroimage | 2020 |
| 32416569 | EEG in fitness to drive evaluations in people with epilepsy - Considerable variations across Europe. | Seizure | 2020 |
| 32385944 | High-frequency electrical stimulation of the anterior thalamic nuclei increases vigilance in epilepsy patients during relaxed and drowsy wakefulness. | Epilepsia | 2020 |
| 32563171 | Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy. | Seizure | 2020 |
| 29618099 | Surgical Treatment of Extratemporal Epilepsy: Results and Prognostic Factors. | Neurosurgery | 2019 |
| 29960857 | Is there a place for surgical treatment of nonpharmacoresistant epilepsy? | Epilepsy Behav | 2019 |
| 31523280 | Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience. | Ther Adv Neurol Disord | 2019 |
| 30924146 | Critique of the 2017 epileptic seizure and epilepsy classifications. | Epilepsia | 2019 |
| 30910450 | Erratum to "Plasma concentration and clinical effects of perampanel-The Kork experience" [Seizure, 67 (April) (2019), 18-22]. | Seizure | 2019 |
| 30852267 | Plasma concentration and clinical effects of perampanel-The Kork experience. | Seizure | 2019 |
| 30782582 | Classification of paroxysmal events and the four-dimensional epilepsy classification system. | Epileptic Disord | 2019 |
| 29307009 | Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections? | J Neurol | 2018 |
| 30083127 | Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany. | Front Neurol | 2018 |
| 29943451 | Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus. | Epilepsia | 2018 |
| 29898967 | European trends in epilepsy surgery. | Neurology | 2018 |
| 30387043 | Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged⿿⿥⿿65 Years with Focal Seizures. | Drugs Aging | 2018 |
| 29587187 | Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers. | Epilepsy Behav | 2018 |
| 29527673 | Adjunctive perampanel for partial-onset seizures. | Acta Neurol Scand | 2018 |